Purpose of this Study
We are doing this study to find out if a new type of assessment works well for middle-aged and older adults with sickle cell disease (SCD). We want to see if this assessment is useful in detecting changes in health. We hope the assessment can provide useful information to help improve the quality of life for adults with sickle cell disease.
Who Can Participate?
Eligibility
Adults ages 40+ who are diagnosed with SCD.
For more information about who can be in this study, please contact the study team at stephanie.padrick@duke.edu.
For more information about who can be in this study, please contact the study team at stephanie.padrick@duke.edu.
Age Range
40-110
Sex/Genders
Male (cisgender)
Female (cisgender)
Non-binary or gender fluid
Transgender male
Transgender female
Looking for Healthy Participants
No
What is Involved?
If you choose to join this study, you will visit our clinic 1-4 times a year for up to 10 years to have the study assessments done. These assessments will take about an hour to finish and will include the following:
- Walking tests
- Balance tests
- Upper-body strength testing and measurement
- Chair stands
- Blood draws and urine collections
- Surveys
During these visits, we will give you an activity monitor to keep track of your physical activity for one week after each visit. This activity monitor fits around your wrist like a watch.
- Walking tests
- Balance tests
- Upper-body strength testing and measurement
- Chair stands
- Blood draws and urine collections
- Surveys
During these visits, we will give you an activity monitor to keep track of your physical activity for one week after each visit. This activity monitor fits around your wrist like a watch.
Locations
Duke University Hospital
Visit Timing
Weekdays
Compensation
Yes
Spanish Materials Available
No
Study Details
Full Title
Focused Geriatric Assessment, Frailty, and Biomarkers to Determine Physiologic Resilience in Older Adults with Sickle Cell Disease (FGA-SCD)
Principal Investigator
Charity
Oyedeji
Protocol Number
PRO00100358
Phase
N/A
Enrollment Status
OPEN TO ACCRUAL